![image.png](https://upload-images.jianshu.io/upload_images/6634703-08fb970627ce985f.png?imageMogr2/auto-orient/strip%7CimageView2/2/w/1240)
![image.png](https://upload-images.jianshu.io/upload_images/6634703-4d9c6c5e9cf9e9ca.png?imageMogr2/auto-orient/strip%7CimageView2/2/w/1240)
![image.png](https://upload-images.jianshu.io/upload_images/6634703-0f1214e3e2a8755d.png?imageMogr2/auto-orient/strip%7CimageView2/2/w/1240)
![image.png](https://upload-images.jianshu.io/upload_images/6634703-d0d40ad0bf77cf11.png?imageMogr2/auto-orient/strip%7CimageView2/2/w/1240)
- (A) Total number of mutations, age at melanoma accession, and mutation subtype (BRAF, RAS [N/H/K], NF1, and Triple-WT) are indicated for each sample (top). (Not shown are one hyper-mutated and one co-occurring NRAS BRAF hot-spot mutant). Color-coded matrix of individual mutations (specific BRAF and NRAS mutations indicated) (middle), type of melanoma specimen (primary or metastasis), and mutation spectra for all samples (bottom) are indicated. For the two samples with both a matched primary and metastatic sample, only the mutation information from the metastasis was included.
![image.png](https://upload-images.jianshu.io/upload_images/6634703-29d86d96b40dc7d0.png?imageMogr2/auto-orient/strip%7CimageView2/2/w/1240)
- (B) BRAF mutations that co-occur with RAS family member and NF1 mutations are illustrated across the BRAF protein.
- C, E 突变比较
- D NF1蛋白的黑素瘤全外显子组测序数据中发现的NF1突变。
######突变通路分析
![](https://upload-images.jianshu.io/upload_images/6634703-ecc076c7842b023f.png?imageMogr2/auto-orient/strip%7CimageView2/2/w/1240)

![image.png](https://upload-images.jianshu.io/upload_images/6634703-c51872fe466fde9d.png?imageMogr2/auto-orient/strip%7CimageView2/2/w/1240)
- A 在染色体上看突变
- B 看哪个基因显著被扩增（星号）
####黑素瘤样本中蛋白质表达水平的分析通过RPPA跨越突变亚型确定单个蛋白质水平。

![image.png](https://upload-images.jianshu.io/upload_images/6634703-af259a953fd0ec72.png?imageMogr2/auto-orient/strip%7CimageView2/2/w/1240)

![image.png](https://upload-images.jianshu.io/upload_images/6634703-f48e4202e20ae3f9.png?imageMogr2/auto-orient/strip%7CimageView2/2/w/1240)
![image.png](https://upload-images.jianshu.io/upload_images/6634703-691e1785bf3149b3.png?imageMogr2/auto-orient/strip%7CimageView2/2/w/1240)
- A and B) (A) Unsupervised clustering of 329 melanoma samples using the top 1,500 genes showing the maximum absolute deviation identify three clusters defined as ‘‘immune-high,” ‘‘keratin-high,” and ‘‘microphthalmia-associated transcription factor (MITF)-low” based on gene function of discriminatory mRNAs and (B) post-accession survival curves for RNA subgroups.
![image.png](https://upload-images.jianshu.io/upload_images/6634703-9df7e58855d77eb6.png?imageMogr2/auto-orient/strip%7CimageView2/2/w/1240)
(C) Distribution of lymphocytic scores determined by histopathology analysis according to sample type 
(D) Post-accession survival curves for high and low lymphocytic infiltration scores.
(E) Overlap of LCK high and low protein expression obtained from RPPA data with lymphocytic infiltration scores determined by pathology and RNA immune subgroups determined by mRNA clustering analysis.
(F) Association of LCK protein with post-accession survival. Three curves describe cumulative survival rates of three tertile patient subsets (p = 0.007 with log-rank test).
####结论
1. 这是和黑色素瘤的最综合的分析（331patient）,构建黑色素瘤的图谱
2. 建立黑色素瘤分型框架: BRAF, RAS, NF1, and Triple-WT
3. 提供可能的靶向治疗方式
4. 多维分析证明免疫特征可以改善生存
